The firm focuses on investing in biotechnology, medical technology, pharmaceuticals, and healthcare innovations that emerge from Spanish research institutions. With a team of experienced investment professionals, Columbus Venture Partners conducts thorough research on the scientific, technological, and commercial potential of these innovations before providing significant capital. Since its establishment, the firm has invested in nine companies spanning various fields such as gene therapy, adaptive immune response, viral vectors research, and polypeptide synthesis.